{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:15:11Z","timestamp":1790752511363,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1038\/s41388-020-1183-x","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T17:04:00Z","timestamp":1581095040000},"page":"2934-2947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Stabilization of \u03b2-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma"],"prefix":"10.1038","volume":"39","author":[{"given":"Gregory","family":"Lazarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Quinquenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhail","family":"Ouriemmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Mihoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bellanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"G\u00e9l\u00e9bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmet","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Ledoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Marzec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cymbalista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Varin-Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gardano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-2927","authenticated-orcid":false,"given":"Fanny","family":"Baran-Marszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"1183_CR1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067\u201378.","journal-title":"Blood."},{"key":"1183_CR2","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101:4975\u201381.","journal-title":"Blood."},{"key":"1183_CR3","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","volume":"84","author":"F Bosch","year":"1994","unstructured":"Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, et al. PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood. 1994;84:2726\u201332.","journal-title":"Blood."},{"key":"1183_CR4","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012;122:3416\u201323.","journal-title":"J Clin Invest."},{"key":"1183_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"P Perez-Galan","year":"2011","unstructured":"Perez-Galan P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood. 2011;117:26\u201338.","journal-title":"Blood."},{"key":"1183_CR6","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou A, Agathangelidis A, Darzentas N, Murray F, Delfau-Larue MH, Pedersen LB, et al. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood. 2011;118:3088\u201395.","journal-title":"Blood."},{"key":"1183_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","volume":"128","author":"NS Saba","year":"2016","unstructured":"Saba NS, Liu D, Herman SE, Underbayev C, Tian X, Behrend D, et al. Pathogenic role of B-cell receptor signaling and canonical NF-kappaB activation in mantle cell lymphoma. Blood. 2016;128:82\u201392.","journal-title":"Blood."},{"key":"1183_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol. 2005;130:516\u201326.","journal-title":"Br J Haematol."},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/ijo.2013.1982","volume":"43","author":"Y Kimura","year":"2013","unstructured":"Kimura Y, Arakawa F, Kiyasu J, Miyoshi H, Yoshida M, Ichikawa A, et al. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: gene expression analysis. Int J Oncol. 2013;43:457\u201368.","journal-title":"Int J Oncol."},{"key":"1183_CR10","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","volume":"112","author":"P Gelebart","year":"2008","unstructured":"Gelebart P, Anand M, Armanious H, Peters AC, Dien Bard J, Amin HM, et al. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood. 2008;112:5171\u20139.","journal-title":"Blood."},{"key":"1183_CR11","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell."},{"key":"1183_CR12","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1101\/gad.11.24.3286","volume":"11","author":"KM Cadigan","year":"1997","unstructured":"Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286\u2013305.","journal-title":"Genes Dev."},{"key":"1183_CR13","doi-asserted-by":"publisher","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","volume":"5","author":"JL Stamos","year":"2013","unstructured":"Stamos JL, Weis WI. The beta-catenin destruction complex. Cold Spring Harb Perspect Biol. 2013;5:a007898.","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785\u20139.","journal-title":"Nature."},{"key":"1183_CR15","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1016\/S0021-9258(18)41866-2","volume":"267","author":"N Goode","year":"1992","unstructured":"Goode N, Hughes K, Woodgett JR, Parker PJ. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem. 1992;267:16878\u201382.","journal-title":"J Biol Chem."},{"key":"1183_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4049\/jimmunol.169.2.758","volume":"169","author":"SL Christian","year":"2002","unstructured":"Christian SL, Sims PV, Gold MR. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. J Immunol. 2002;169:758\u201369.","journal-title":"J Immunol."},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422\u20136.","journal-title":"Nature."},{"key":"1183_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509\u201312.","journal-title":"Science."},{"key":"1183_CR19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172\u201383.","journal-title":"Mol Cell Biol."},{"key":"1183_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson KM, Anderson NG. The protein kinase B\/Akt signalling pathway in human malignancy. Cell Signal. 2002;14:381\u201395.","journal-title":"Cell Signal."},{"key":"1183_CR21","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3324\/haematol.2009.019745","volume":"95","author":"F Baran-Marszak","year":"2010","unstructured":"Baran-Marszak F, Boukhiar M, Harel S, Laguillier C, Roger C, Gressin R, et al. Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma. Haematologica. 2010;95:1865\u201372.","journal-title":"Haematologica."},{"key":"1183_CR22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/ijc.29326","volume":"136","author":"S Bernard","year":"2014","unstructured":"Bernard S, Danglade D, Gardano L, Laguillier C, Lazarian G, Roger C, et al. Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma. Int J Cancer. 2014;136:2761\u201374.","journal-title":"Int J Cancer."},{"key":"1183_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-065X.2000.00601.x","volume":"176","author":"MR Gold","year":"2000","unstructured":"Gold MR, Ingham RJ, McLeod SJ, Christian SL, Scheid MP, Duronio V, et al. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev. 2000;176:47\u201368.","journal-title":"Immunol Rev."},{"key":"1183_CR24","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.4161\/cc.7.18.6733","volume":"7","author":"J Dal Col","year":"2008","unstructured":"Dal Col J, Dolcetti R. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma. Cell Cycle. 2008;7:2813\u20136.","journal-title":"Cell Cycle."},{"key":"1183_CR25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.163.4.1894","volume":"163","author":"MR Gold","year":"1999","unstructured":"Gold MR, Scheid MP, Santos L, Dang-Lawson M, Roth RA, Matsuuchi L, et al. The B cell antigen receptor activates the Akt (protein kinase B)\/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol. 1999;163:1894\u2013905.","journal-title":"J Immunol."},{"key":"1183_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2162-3619-2-4","volume":"2","author":"MA Boukhiar","year":"2013","unstructured":"Boukhiar MA, Roger C, Tran J, Gressin R, Martin A, Ajchenbaum-Cymbalista F, et al. Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma. Exp Hematol Oncol. 2013;2:4.","journal-title":"Exp Hematol Oncol."},{"key":"1183_CR27","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1038\/onc.2015.493","volume":"35","author":"MK Bognar","year":"2016","unstructured":"Bognar MK, Vincendeau M, Erdmann T, Seeholzer T, Grau M, Linnemann JR, et al. Oncogenic CARMA1 couples NF-kappaB and beta-catenin signaling in diffuse large B-cell lymphomas. Oncogene. 2016;35:4269\u201381.","journal-title":"Oncogene."},{"key":"1183_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/34956","volume":"391","author":"FE Chen","year":"1998","unstructured":"Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50\/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature. 1998;391:410\u20133.","journal-title":"Nature."},{"key":"1183_CR29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1073\/pnas.1118506109","volume":"109","author":"JA Raskatov","year":"2012","unstructured":"Raskatov JA, Meier JL, Puckett JW, Yang F, Ramakrishnan P, Dervan PB. Modulation of NF-kappaB-dependent gene transcription using programmable DNA minor groove binders. Proc Natl Acad Sci USA. 2012;109:1023\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1183_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1535-6108(03)00334-9","volume":"5","author":"M Lepourcelet","year":"2004","unstructured":"Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, et al. Small-molecule antagonists of the oncogenic Tcf\/beta-catenin protein complex. Cancer Cell. 2004;5:91\u2013102.","journal-title":"Cancer Cell."},{"key":"1183_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2141.2007.06667.x","volume":"138","author":"NI Khan","year":"2007","unstructured":"Khan NI, Bradstock KF, Bendall LJ. Activation of Wnt\/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol. 2007;138:338\u201348.","journal-title":"Br J Haematol."},{"key":"1183_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2174\/156800910793605794","volume":"10","author":"RK Gandhirajan","year":"2010","unstructured":"Gandhirajan RK, Poll-Wolbeck SJ, Gehrke I, Kreuzer KA. Wnt\/beta-catenin\/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options. Curr Cancer Drug Targets. 2010;10:716\u201327.","journal-title":"Curr Cancer Drug Targets."},{"key":"1183_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/onc.2014.181","volume":"34","author":"M Spaargaren","year":"2015","unstructured":"Spaargaren M, de Rooij MF, Kater AP, Eldering E. BTK inhibitors in chronic leukemia: a glimpse to the future. Oncogene. 2015;34:2426\u201336.","journal-title":"Oncogene."},{"key":"1183_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0006-291X(02)00382-0","volume":"293","author":"J Lindvall","year":"2002","unstructured":"Lindvall J, Islam TC. Interaction of Btk and Akt in B cell signaling. Biochem Biophys Res Commun. 2002;293:1319\u201326.","journal-title":"Biochem Biophys Res Commun"},{"key":"1183_CR35","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1182\/blood-2014-12-619163","volume":"125","author":"MF de Rooij","year":"2015","unstructured":"de Rooij MF, Kuil A, Kater AP, Kersten MJ, Pals ST, Spaargaren M. Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy. Blood. 2015;125:2306\u20139.","journal-title":"Blood."},{"key":"1183_CR36","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2890","volume":"18","author":"Y Sun","year":"2012","unstructured":"Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med. 2012;18:1359\u201368.","journal-title":"Nat Med."},{"key":"1183_CR37","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1038\/onc.2015.494","volume":"35","author":"Y Sun","year":"2016","unstructured":"Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016;35:4321\u201334.","journal-title":"Oncogene."},{"key":"1183_CR38","doi-asserted-by":"crossref","unstructured":"Lovatt M, Bijlmakers MJ. Stabilisation of beta-catenin downstream of T cell receptor signalling. PLoS ONE. 2010;5:e12794.","DOI":"10.1371\/journal.pone.0012794"},{"key":"1183_CR39","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3389\/fimmu.2017.01086","volume":"8","author":"T Koopmans","year":"2017","unstructured":"Koopmans T, Eilers R, Menzen M, Halayko A, Gosens R. beta-catenin directs nuclear Factor-kappaB p65 output via CREB-binding protein\/p300 in human airway smooth muscle. Front Immunol. 2017;8:1086.","journal-title":"Front Immunol."},{"key":"1183_CR40","first-page":"378","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma B, Hottiger MO. Crosstalk between Wnt\/beta-Catenin and NF-kappaB signaling pathway during Inflammation. Front Immunol. 2016;7:378.","journal-title":"Front Immunol."},{"key":"1183_CR41","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. EMBO J. 2012;31:2714\u201336.","journal-title":"EMBO J."},{"key":"1183_CR42","first-page":"2344","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang X, Hao J. Development of anticancer agents targeting the Wnt\/beta-catenin signaling. Am J Cancer Res. 2015;5:2344\u201360.","journal-title":"Am J Cancer Res."},{"key":"1183_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","volume":"8","author":"R Mathur","year":"2015","unstructured":"Mathur R, Sehgal L, Braun FK, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63.","journal-title":"J Hematol Oncol."},{"key":"1183_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033976","volume":"7","author":"RM Hallett","year":"2012","unstructured":"Hallett RM, Kondratyev MK, Giacomelli AO, Nixon AM, Girgis-Gabardo A, Ilieva D, et al. Small molecule antagonists of the Wnt\/beta-catenin signaling pathway target breast tumor-initiating cells in a Her2\/Neu mouse model of breast cancer. PLoS ONE. 2012;7:e33976.","journal-title":"PLoS ONE."},{"key":"1183_CR45","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1038\/sj.onc.1208568","volume":"24","author":"J Mazieres","year":"2005","unstructured":"Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, et al. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene. 2005;24:5396\u2013400.","journal-title":"Oncogene."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1183-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-1183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:44:37Z","timestamp":1695732277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,4,2]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-1183-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}